Medical Devices and Combination Products
The revisions to the Medical Device Regulation and In-Vitro Diagnostic Regulation are transforming the European device market. At the same time, digital disruption is dramatically transforming pharmaceutical development, with many pharma manufacturers now pairing their treatments with different digital tools such as apps for monitoring or improving adherence. This track will highlight how regulations have the potential to bring medicines and devices ever closer and explore how software is changing existing treatment paradigms.
Who is This Track Designed For?
Regulatory professionals in the medical device industry or those working with combination products, software developers, research and development managers, portfolio managers, strategy professionals and digital health professionals.